NORTHWAY BIOLOGICS
Live / Registered — Registered (as of 27 Sept 2022)
What this means for you
Registered since 27 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79301526
- Registration number
- 6854456
- Mark type
- Design + words
- Filed
- 18 Nov 2020
- Published for opposition
- 14 Dec 2021
- Registered
- 27 Sept 2022
- Attorney of record
- JOHN ZACCARIA
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological preparations for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological tissue cultures for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; albuminous preparations for medical purposes, namely, albumin dietary supplements; chemical preparations for medical purposes, namely, for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19
- Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto, namely, research and design in the field of products and processes development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; conducting clinical trials for others; scientific research; medical research; scientific laboratory services; technical research in the field of pharmaceutical studies; technological consultancy in the field of development of manufacturing processes for biotechnology products
Owner
Prosecution history
- 07 Feb 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 18 Jan 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 18 Jan 2023 — FINAL DISPOSITION PROCESSED
- 27 Dec 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 27 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 24 Aug 2022 — TTAB RELEASE CASE TO TRADEMARKS
- 24 Aug 2022 — OPPOSITION TERMINATED NO. 999999
- 24 Aug 2022 — OPPOSITION DISMISSED NO. 999999
- 04 Jul 2022 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 13 Jun 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 08 Jun 2022 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 06 Feb 2022 — REFUSAL PROCESSED BY IB
- 20 Jan 2022 — OPPOSITION INSTITUTED NO. 999999
- 11 Jan 2022 — OPPOSITION PAPERS RECEIVED AT TTAB